A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain

Pain

Volumn 76, Issue 3, 1998, Pages 287-296

  Hampton Atkinson, J ^a,b   Slater, Mark A ^a,b   Williams, Rebecca A ^a   Zisook, Sidney ^a,b   Patterson, Thomas L ^a,b   Grant, Igor ^a,b   Wahlgren, Dennis R ^a,d   Abramson, Ian ^e   Garfin, Steven R ^a,c  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAN DIEGO STATE UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Analgesia; Antidepressants; Back pain

Indexed keywords

NORTRIPTYLINE; PLACEBO; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ANALGESIA; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED STUDY; DISABILITY; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; HEADACHE; HEART PALPITATION; HUMAN; INSOMNIA; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEDATION; SIDE EFFECT; SWEATING; TREATMENT OUTCOME; XEROSTOMIA;

ADULT; AFFECT; AGED; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; LOW BACK PAIN; MALE; MIDDLE AGED; NORTRIPTYLINE; PAIN MEASUREMENT; PLACEBOS; QUALITY OF LIFE; SICKNESS IMPACT PROFILE;

EID: 0032103793     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(98)00064-5     Document Type: Article

References (58)

1. Alcoff J., Jones E., Rust P., Newman R. Controlled trial of imipramine for chronic low back pain. J. Fam. Pract. 14:1982;841-846.
2. Atkinson, J.H., Slater, M.A., Doctor, J.N. and Klapow, J.C., Psychopharmacologic agents in the treatment of pain. In: C.D. Tollison, J.R. Satterthwaite and J.W. Tollison (Eds.), Handbook of Pain Management (2nd ed.), Williams and Wilkins, Baltimore, 1993, pp. 181-214.
3. Atkinson J.H., Slater M.A., Patterson T.L., Grant I., Garfin S.R. Prevalence, onset, and risk of psychiatric disorders in men with chronic low back pain: A controlled study. Pain. 45:1991;111-121.
4. Baldessarini R.J. Current status of antidepressants: Clinical pharmacology and therapy. J. Clin. Psychiatry. 50:1989;117-126.
5. Beck, A.T., Depression: Clinical, Experimental and Theoretical Aspects, Hoeber, New York, 1967.
6. Beck A.T., Steer R.A., Garbin M.G. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin. Psychol. Rev. 8:1988;77-100.
7. Broadhead W.E., Larson D.B., Yarnall K.S.H., Blazer D.G., Tsc C.-K.J. Tricyclic antidepressants prescribing for nonpsychiatric disorder. An analysis based on data from the 1985 National Ambulatory Medical Care Survey. J. Fam. Pract. 33:1991;24-32.
8. Deyo R.A. Conservative therapy for low back pain: Distinguishing useful from useless therapy. J. Am. Med. Assoc. 250:1983;1057-1062.
9. Deyo R.A., Diehl A.K. Measuring physical and psychosocial function in patients with low back pain. Spine. 8:1983;635-642.
10. Doctor J.N., Slater M.A., Atkinson J.H. The descriptor differential scale of pain intensity: An evaluation of item and scale properties. Pain. 61:1995;251-260.
11. Follick M.J., Smith T.W., Ahern D.K. The Sickness Impact Profile: A global measure of disability in chronic low back pain. Pain. 21:1985;67-76.
12. France, R.D. and Krishnan, K.R.R. (Eds.), Chronic Pain, American Psychiatric Association Press, Washington, DC, 1988.
13. Frymoyer J.W., Cats-Baril W.L. An overview of the incidence and costs of low back pain. Orthop. Clin. North. Am. 22:1991;263-271.
14. Gilson B.S., Gilson J.S., Bergner M., Bobbit R.A., Kressel S., Pollard W.E., Vesselago M. Sickness Impact Profile: Development of an outcome measure of health care. Am. J. Public Health. 65:1975;1304-1310.
15. Goodkin K., Gullion C.M. Antidepressants for the relief of chronic pain: Do they work? Ann. Behav. Med. 11:1989;83-101.
16. Goodkin K., Gullion C.M., Agras W.S. A randomized, double-blind placebo controlled trial of trazodone hydrochloride in chronic low back pain syndrome. J. Clin. Psychopharmacol. 10:1990;269-278.
17. Gracely R.H., Kwilosz D.M. The Descriptor Differential Scale: Applying psychophysical principles to clinical pain assessment. Pain. 35:1988;279-288.
18. Guy, W., Clinical Global Impressions, ECDEU Assessment Manual for Psychopharmacology, US Government Printing Office, Washington, DC, 1976.
19. Hameroff S.R., Cork R.C., Scherer K., Crago B.R., Neuman C., Womble J.R., Davis T.P. Doxepin effects on chronic pain, depression and plasma opioids. J. Clin. Psychiatry. 43:1982;22-27.
20. Hamilton M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 32:1959;50-55.
21. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 23:1960;56-62.
22. Hamilton M. General problems of psychiatric rating scales (especially for depression). Mod. Prob. Pharmacother. 7:1974;125-138.
23. Janicak, P.G., Davis, J.M., Preskorn, S.H. and Ayd. F.J. Jr., Principles and Practice of Psychopharmacotherapy, Williams and Wilkins, Baltimore, 1993.
24. Jenkins D.G., Ebbutt A.F., Evans C.D. Tofranil in the treatment of low back pain. J. Int. Med. Res. 4(S2):1976;28-40.
25. Jensen M.P., Strom S.E., Turner J.A., Romano J.M. Validity of the Sickness Impact Profile scale as a measure of dysfunction in chronic pain patients. Pain. 50:1992;157-162.
26. Jensen M.P., Turner J.A., Romano J.M. Correlates of improvement in multidisciplinary treatment of chronic pain. J. Consult. Clin. Psychiatry. 62:1994;172-179.
27. Kaplan R.M., Bush J.Q. Health-related quality of life measurement for evaluation research and policy analysis. Health Psychol. 1:1982;61-80.
28. Kishore-Kumar R., Max M.B., Schafer S.C., Gaughan A.M., Smoller B., Gracely R.H., Dubner R. Desipramine relieves postherpetic neuralgia. Clin. Pharmacol. Ther. 47:1990;305-312.
29. Krishnan K.R.R., France R.D., Pelton S., McCann U.D., Davidson J., Urban B.J. Chronic pain and depression I. Classification of depression in chronic low back pain patients. Pain. 22:1985;289-294.
30. Kvinesdal B., Molin J., Froland A., Gram L.F. Imipramine treatment of painful diabetic neuropathy. J. Am. Med. Assoc. 251:1984;1727-1730.
31. Lakotas, L.M., Slater, M.A., Atkinson, J.H., Grant, I. and Garfin, S.R., Assessing health status and quality of life in chronic low back pain. Poster presentation at the 8th Annual Scientific Meeting of the American Pain Society, Phoenix, AZ, October 26-29, 1989.
32. Lemrow, N., Adams. D. and Coffey, R., The 50 most frequent diagnosis-related groups (DRGs), diagnoses, and procedures: Statistics by hospital size and location, DHHS Publication no. (PHS) 90-3465, Hospital Studies Program Research Note 13, Agency for Health Care Policy and Research, Public Health Service, Rockville, MD, September, 1990.
33. Max, M.B., Antidepressants as analgesics.In: H.L. Fields and J.C. Liebeskind (Eds.), Progress in Pain Research and Management vol. 1, IASP Press, Seattle, 1994, pp. 229-246.
34. Max M.B., Culnane M., Schafer S.C., Gracely R.H., Walther D.J., Smoller B., Dubner R. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology. 37:1987;589-596.
35. Max M.B., Schafer S.C., Culnane M., Smoller B., Dubner R., Gracely R.H. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology. 38:1988;427-1432.
36. Max M.B., Kishore-Kumar R., Schafer S.C., Meister B., Gracely R.H., Smoller B., Dubner R. Efficacy of desipramine in painful diabetic neuropathy: A placebo-controlled trial. Pain. 45:1991;3-9.
37. Max M.B., Lynch S.A., Muir J., Shoaf S.E., Smoller B., Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N. Engl. J. Med. 326:1992;1250-1256.
38. Moscucci M., Byrne L., Weintraub M., Cox C. Blinding, unblinding, and the placebo effect: An analysis of patients' guesses of treatment assignment in a double-blind clinical trial. Clin. Pharmacol. Ther. 41:1987;259-265.
39. Onghena P., Van Houdenhove B. Antidepressant induced analgesia in chronic non-malignant pain: A meta-analysis of 39 placebo-controlled studies. Pain. 49:1992;205-219.
40. Pheasant H., Bursk A., Goldfarb J., Azen S.P., Weiss J.N., Borelli L. Amitriptyline and chronic low back pain. Spine. 8:1983;552-557.
41. Rabkin J.G., Markowitz J.S., Ocepek-Welikson K., Wagner S. General versus systemic inquiry about medication side-effects with SAFTEE: Implications for clinical research. J. Clin. Psychopharmacol. 12:1992;3-10.
42. Richelson, E., Antidepressants: Pharmacology and clinical use. In: American Psychiatric Association Task Force on Treatments of Psychiatric Disorders. Treatments of Psychiatric Disorders, vol. 3, American Psychiatric Association, Washington, DC, 1989, pp. 1773-1786.
43. Seltzer Z., Tal M., Sharav Y. Autonomy behavior in rats following peripheral deafferentation is suppressed by daily injection of amitriptyline, diazepam, and saline. Pain. 37:1989;245-250.
44. Sindrup S.H., Gram L.F., Skjold T., Froland A., Beck-Nielsen H. Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms. Clin. Pharmacol. Ther. 47:1990;509-515.
45. Spiegel K., Kalb R., Pasternak W. Analgesic activity of tricyclic antidepressants. Ann. Neurol. 13:1983;462-465.
46. Spielberger, C.D., Gorsuch, R.L. and Lushene, R.E., STAI Manual for the State-Trait Anxiety Inventory, Consulting Psychologists Press, Palo Alto, CA, 1969.
47. Spitzer W.O., LeBlanc F.E., Dupuis M. Scientific approach to the assessment and management of activity-related spinal disorders. Spine. 12:1987;S1-59.
48. Spitzer, R., Williams, J., Gibbo, M. and First, M., Structured Clinical Interview for DSM III-R (Non patient version), American Psychiatric Association, Washington, DC, 1990.
49. Turner J.A., Denny M.C. Do antidepressant medications relieve chronic low back pain? J. Fam. Pract. 37:1993;545-553.
50. Turner J.A., Deyo R.A., Loeser J.D., VonKorff M., Fordyce W.E. The importance of placebo effects in pain treatment and research. J. Am. Med. Assoc. 271:1994;1609-1614.
51. United States Department of Commerce, Statistical Abstracts, 113th ed., Tables 579 and 587, 1993.
52. Waddell G., Main C.J. Assessment of severity in low back disorders. Spine. 9:1984;204-208.
53. Ward N.G. Tricyclic antidepressants for chronic low back pain. Spine. 11:1986;661-665.
54. Ward N.G., Bloom V.L., Friedel R.C. The effectiveness of tricyclic antidepressants in the treatment of coexisting pain and depression. Pain. 7:1979;331-341.
55. Watson C.P.N., Chipman M., Reed K., Evans R.J., Birkett N. Amitriptyline versus maprotiline in post-herpetic neuralgia: A randomized, double blind, crossover trial. Pain. 48:1992;29-36.
56. Watson C.P., Evans R.J., Reed K., Merskey H., Goldsmith L., Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology. 32:1982;671-673.
57. Williams J.B.W. A structured interview for the Hamilton Depression Rating Scale. Arch. Gen. Psychiatry. 45:1988;742-747.
58. Yaksh T.L., Al-Rodhan N.R.F., Jensen T.S. Sites of action of opiates in production of analgesia. Prog. Brain Res. 77:1988;371-394.